Development of an instrument to measure parents' preferences and goals for the treatment of attention deficit-hyperactivity disorder
- PMID: 22748759
- PMCID: PMC3456970
- DOI: 10.1016/j.acap.2012.04.009
Development of an instrument to measure parents' preferences and goals for the treatment of attention deficit-hyperactivity disorder
Abstract
Objectives: To describe the development and validation of an instrument to measure parents' attention deficit-hyperactivity disorder (ADHD) treatment preferences and goals.
Methods: Parents of children 6 to 12 years of age diagnosed with ADHD in the past 18 months were recruited from 8 primary care sites and an ADHD treatment center (autism excluded). A 16-item medication, 15-item behavior therapy preference scale and a 23-item goal scale, were developed after a review of the literature, 90 parent and clinician semistructured interviews, and input from parent advocates and professional experts were administered to parents. Parent cognitive interviews confirmed item readability, clarity, content, and response range. We conducted an exploratory factor analysis and assessed internal consistency and test-retest reliability and construct and concurrent validity.
Results: We recruited 237 parents (mean child age 8.1 years, 51% black, 59% from primary care, 61% of children medication naive). Factor analyses identified 4 medication preference subscales (treatment acceptability, feasibility, stigma, and adverse effects, Cronbach's α 0.74-0.87); 3 behavior therapy subscales (treatment acceptability, feasibility, and adverse effects, α 0.76-0.83); and 3 goal subscales (academic achievement, behavioral compliance, and interpersonal relationships, α 0.83-0.86). The most strongly endorsed goal was academic achievement. The scales demonstrated construct validity, concurrent validity (r = 0.3-0.6) compared with the Treatment Acceptability Questionnaire and Impairment Rating Scale and moderate to excellent test-retest reliability (intraclass coefficient = 0.7-0.9).
Conclusions: We developed a valid and reliable instrument for measuring preferences and goals for ADHD treatment, which may help clinicians more easily comply with new national treatment guidelines for ADHD that emphasize shared decision making.
Copyright © 2012 Academic Pediatric Association. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Financial Disclosure and Conflicts of Interest: None.
Figures
Similar articles
-
Parental preferences and goals regarding ADHD treatment.Pediatrics. 2013 Oct;132(4):692-702. doi: 10.1542/peds.2013-0152. Epub 2013 Sep 2. Pediatrics. 2013. PMID: 23999959 Free PMC article. Review.
-
Development and Validation of the Parental Smartphone Use Management Scale (PSUMS): Parents' Perceived Self-Efficacy with Adolescents with Attention Deficit Hyperactivity Disorder.Int J Environ Res Public Health. 2019 Apr 21;16(8):1423. doi: 10.3390/ijerph16081423. Int J Environ Res Public Health. 2019. PMID: 31010068 Free PMC article.
-
A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.Pediatrics. 2005 Jan;115(1):e97-104. doi: 10.1542/peds.2004-0953. Pediatrics. 2005. PMID: 15629972
-
The attention-deficit/hyperactivity disorder medication-related attitudes of patients and their parents.J Child Adolesc Psychopharmacol. 2008 Oct;18(5):461-73. doi: 10.1089/cap.2008.023. J Child Adolesc Psychopharmacol. 2008. PMID: 18928411
-
Systematic Review of Patients' and Parents' Preferences for ADHD Treatment Options and Processes of Care.Patient. 2015 Dec;8(6):483-97. doi: 10.1007/s40271-015-0112-5. Patient. 2015. PMID: 25644223 Review.
Cited by
-
Six Stages of Engagement in ADHD Treatment Described by Diverse, Urban Parents.Pediatrics. 2021 Oct;148(4):e2021051261. doi: 10.1542/peds.2021-051261. Epub 2021 Sep 16. Pediatrics. 2021. PMID: 34531290 Free PMC article.
-
A scoping review and assessment of essential elements of shared decision-making of parent-involved interventions in child and adolescent mental health.Eur Child Adolesc Psychiatry. 2021 Sep;30(9):1319-1338. doi: 10.1007/s00787-020-01530-7. Epub 2020 Apr 16. Eur Child Adolesc Psychiatry. 2021. PMID: 32300893 Free PMC article. Review.
-
Affiliate Stigma and Related Factors in Family Caregivers of Children with Attention-Deficit/Hyperactivity Disorder.Int J Environ Res Public Health. 2020 Jan 16;17(2):576. doi: 10.3390/ijerph17020576. Int J Environ Res Public Health. 2020. PMID: 31963190 Free PMC article.
-
Assessing the Safety of Custom Web-Based Clinical Decision Support Systems in Electronic Health Records: A Case Study.Appl Clin Inform. 2019 Mar;10(2):237-246. doi: 10.1055/s-0039-1683985. Epub 2019 Apr 3. Appl Clin Inform. 2019. PMID: 30943572 Free PMC article.
-
ADHD in children and youth: Part 2-Treatment.Paediatr Child Health. 2018 Nov;23(7):462-472. doi: 10.1093/pch/pxy113. Epub 2018 Oct 24. Paediatr Child Health. 2018. PMID: 30681665 Free PMC article. Review.
References
-
- Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango) Soc Sci Med. 1997;44(5):681–692. - PubMed
-
- O'Connor AM, Bennett CL, Stacey D, Barry M, Col NF, Eden KB, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2009;(3) CD001431. - PubMed
-
- Institute of Medicine (U.S.) Initial National Priorities for Comparative Effectiveness Research. Washington, D.C.: National Academy Press; 2009. Committee on Comparative Effectiveness Research Prioritization.
-
- The Patient Protection and Affordable Care Act. Public Law No:111-148, 124 Stat 1025; 111th Congress; United States of America. 2010.
-
- Mental Health in the United States: Prevalence of Diagnosis and Medication Treatment for Attention-Deficit/Hyperactivity Disorder --- United States, 2003. MMWR. 2005;54(34):842–847. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
